Adhera Therapeutics
(OTC) ATRX
Adhera Therapeutics Financials at a Glance
Market Cap
$700.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$4.49M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-291.26 (Low)
Dividend
$0.00
Beta (Volatility)
-291.26 (Low)
Price
$0.00
Volume
1
Open
$0.00
Price
$0.00
Volume
1
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
Estimated Earnings Date
Nov 25, 2024
Dividend
$0.00
Beta (Volatility)
-291.26 (Low)
Price
$0.00
Volume
1
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
Estimated Earnings Date
Nov 25, 2024
ATRX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Adhera Therapeutics
Industry
Biotechnology
Sector
Health CareCEO
Zahed Subhan, PhD, MBA
Website
www.adherathera.comHeadquarters
Baton Rouge, LA 70820, US
ATRX Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
8.94%
Return on Capital
N/A
Return on Assets
-2675.95%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$700.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
7.22M
Volume
1
Avg. Volume
118.871
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$1.28M
EBITDA
$1.01M
Operating Cash Flow
-$808.16K
Capital Expenditure
$0.00
Free Cash Flow
-$808.16K
Cash & ST Invst.
$32.39K
Total Debt
$10.83M
Adhera Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$700.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$350.00
N/A
Employees
2
N/A
Net Income
-$3.54M
-96.1%
EBITDA
-$2.66M
-1548.7%
Quarterly Fundamentals
Total Cash
$32.39K
-75.6%
Total Debt
$10.83M
+35.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$10.09M
+26.2%
Return on Assets
-26.76%
N/A
Return on Invested Capital
7.29%
N/A
Free Cash Flow
-$29.16K
+94.9%
Operating Cash Flow
-$29.16K
+94.9%